Bray June — SEC Form 4 filings

SEC reporting owner CIK 1845487. 6 Form 4 filings on record with FilingPulse; latest filed 2026-01-21.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-06-07 to 2026-01-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Quince Therapeutics, Inc. (QNCX)Director44
BioXcel Therapeutics, Inc. (BTAI)Director22

Form 4 filings — Bray June

FiledFormIssuerReported transactionsSource
2026-01-214Quince Therapeutics, Inc. (QNCX)Grant/award (A): 18,724 (derivative) @ $0EDGAR
2026-01-124BioXcel Therapeutics, Inc. (BTAI)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2025-06-064Quince Therapeutics, Inc. (QNCX)Grant/award (A): 27,000 (derivative) @ $0EDGAR
2025-01-084Quince Therapeutics, Inc. (QNCX)Grant/award (A): 30,282 (derivative) @ $0EDGAR
2024-06-114BioXcel Therapeutics, Inc. (BTAI)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2024-06-074Quince Therapeutics, Inc. (QNCX)Grant/award (A): 27,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1845487 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →